Client trainingVisited 0 of 32 modulesGoals and progress
One growth initiative a month: what we are aiming for, why, how it is going, and who does what. Benchmark updates this page at every close. Updated October 8, 2026.
Build capacity behind Ava: route new injectable patients to Provider 2
Target: Ava under 45% of provider revenue by December; Provider 2 above $50,000 a month.
Sample month. The layout is real; the counts are illustrative.
Why this one
- One injector at 47% of revenue is a burnout risk today and a discount at sale: buyers price a provider above about 35% at half a turn to a full turn of multiple (Advanced finance 5).
- Provider 2 is at 61% rebook and $500 an hour with an unfilled book. The capacity exists; the routing does not.
- Every new patient who starts with Provider 2 is a patient whose loyalty is to the clinic, not to one person.
New injectable patients booked with Provider 2, by week
By person
| Who | Count | Earned |
|---|---|---|
| Front desk lead Front desk | 31bonus | $460 |
| Front desk, weekends Front desk | 14 | $140 |
| Phone and DMs Shared inbox | 11 | $110 |
| Total incentives | 56 | $710 |
$10 per new patient booked with Provider 2, $150 bonus at 25 in a month. Incentives capped at 5% of Provider 2's new patient revenue.
The plan
- Desk routes new injectable inquiries to Provider 2 by default; Ava takes returning and complex
- Provider 2 shadows Ava on two consults a week for a month
- Desk incentive: $10 per new patient booked with Provider 2, $150 bonus at 25
- Website and profile updated: Provider 2's page, photos and reviews
- Weekly count every Friday; share by provider on the scorecard
- Review Provider 2's pay plan once her book passes $50,000
How Benchmark helps
- Showed the concentration on the scorecard every month until it became the initiative.
- Designed the routing rule with the desk and the incentive so it pays for itself.
- Updated the website, the Google profile and the review requests to feature Provider 2.
- Count weekly, report by person, and put share by provider on page two of the scorecard.
- Reprice Provider 2's plan when her book crosses the line, so she is paid for the growth.
What Harbor Aesthetics does
- Ava names Provider 2 in the room: 'She trained with me; she'll take great care of you.'
- The desk offers Provider 2's times first to every new injectable patient.
- Tell us the same week if a patient insists on Ava, so we can see the pattern.
Past initiatives
Rebook at checkout from 60% to 65%August 2026
Rebook at checkout from 60% to 65%
Target: 65% of visits rebooked before the patient leaves.
Sample month. The layout is real; the counts are illustrative.
Why this one
- Rebook is the cheapest revenue in the building: a patient kept for a year is worth about $1,600 with no acquisition cost.
- The gap between the best desk person (71%) and the rest (54%) was a script gap, not a talent gap.
Visits rebooked at checkout, by week
By person
| Who | Rate |
|---|---|
| Front desk lead Front desk | 72% |
| Front desk, weekends Front desk | 63% |
No incentive; measured and coached weekly.
The plan
- Providers name the return date in the room
- Desk offers two specific times before payment
- Rebook by desk person on the weekly count
How Benchmark helps
- Wrote the script with the desk.
- Reported rebook by person every Friday.
What Harbor Aesthetics does
- Every provider named the date in the room.
- The desk asked before payment, every time.
This quarter's plan
0 of 7 milestones done. Set at the September review from the scorecard; refreshed at each close.
October to December
Q4 plan- Ava under 45% of provider revenue
- Annual prepay membership tier launched; 40 conversions
- Rebook at checkout at 70%
- Cash runway at two months; device decision revisited
- Filler marketing shifted to biostimulators; line growth checked in December
- Year end tax planning call with the CPAOctober, before decisions stop mattering.
- 1099 vendor list and W-9 check
Decisions we have made together
So nobody has to remember why, and so a buyer's accountant can read the reasoning in year three.
| When | Decision | Why |
|---|---|---|
| Apr 2026 | Books moved to the accrual basis; packages and memberships in deferred revenue | Revenue earned as delivered. Buyers and lenders read accrual books. |
| May 2026 | Neurotoxin commission base changed from gross revenue to revenue net of product | The old plan paid the injector more than the clinic on every price increase. |
| Jun 2026 | Two evening blocks added, Tuesday and Thursday | The heat map showed a waitlist at 5 to 7pm and empty Tuesday mornings. |
| Sep 2026 | Neurotoxin repriced by $1 a unit, members held at the old rate through December | The July supplier increase had cost 3 points of margin for two months. |
How the numbers fit in
Each month's initiative comes from the scorecard: the number that moved, or the one that will move the value of the clinic most. See the dashboard and the value tracker.